Literature DB >> 1679459

Progesterone receptor gene restriction fragment length polymorphisms in human breast tumors.

S A Fuqua1, S M Hill, G C Chamness, M G Benedix, G L Greene, B W O'Malley, W L McGuire.   

Abstract

We examined the progesterone receptor (PgR) gene in tissue from both primary human breast tumors and normal placentas, detecting restriction fragment length polymorphisms (RFLPs) with the restriction endonucleases Pst I/Sst I and HindIII. There was a general agreement of the Pst I and Sst I polymorphisms in any individual tumor, suggesting that they define two alleles in the human PgR locus, one being characterized by a deletion of about 300 base pairs with respect to the other. Both primary human breast tumor specimens (n = 36) and human term placentas (n = 48) displayed similar allele frequencies and typical mendelian distribution of these Pst I/Sst I alleles. The previously reported HindIII PgR RFLP was also investigated in 132 breast tumors. The HindIII PgR gene RFLP did not display typical mendelian distribution in the breast tumors; the factors affecting the HindIII allele frequencies are presently unknown. Neither the HindIII RFLP nor the deletion defined by Pst I and Sst I correlated with PgR expression as determined by a ligand-binding assay, suggesting that neither is related to the heterogeneity of PgR expression seen in breast tumors.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1679459     DOI: 10.1093/jnci/83.16.1157

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  4 in total

Review 1.  DNA methylation: an alternative pathway to cancer.

Authors:  S A Wajed; P W Laird; T R DeMeester
Journal:  Ann Surg       Date:  2001-07       Impact factor: 12.969

Review 2.  The loss of estrogen and progesterone receptor gene expression in human breast cancer.

Authors:  R G Lapidus; S J Nass; N E Davidson
Journal:  J Mammary Gland Biol Neoplasia       Date:  1998-01       Impact factor: 2.673

3.  Progesterone Receptor Gene Variants in Metastatic Estrogen Receptor Positive Breast Cancer.

Authors:  Amy M Fowler; Kelley Salem; Michael DeGrave; Irene M Ong; Shane Rassman; Ginny L Powers; Manoj Kumar; Ciara J Michel; Aparna M Mahajan
Journal:  Horm Cancer       Date:  2020-01-16       Impact factor: 3.869

4.  A germline TaqI restriction fragment length polymorphism in the progesterone receptor gene in ovarian carcinoma.

Authors:  N J McKenna; D G Kieback; D N Carney; M Fanning; J McLinden; D R Headon
Journal:  Br J Cancer       Date:  1995-03       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.